Perlmutter Cancer Center Advances Care in Brooklyn
Dr. Thomas B. Daniels has been appointed service chief of radiation oncology at Perlmutter Cancer Center—Sunset Park.
prmeir-scholars-summer-intensive-program-application.pdf
... 19 years ago, NYU Grossman School of Medicine established the Program for Medical Education ... and internationally. PrMEIR’s mission is to advance medical education scholarship and institute best practices ...
Restricted Blood Flow Speeds Tumor Growth
Researchers at NYU Langone Health found that cutting off blood flow anywhere in the body drives cancer growth.
Robotic Surgery Used to Successfully Treat Kidney Cancer
An incidental discovery of a kidney tumor in a chest scan leads NYU Lutheran doctors to perform robotic surgery for kidney cancer.
This document outlines the criteria for rank and the procedures for advancement and promotion of full-time faculty at New York
... and engagement of the library faculty. Creation of such a track addressed concerns around parity in medical ... . Specifics of this new track can be found on pages 19-20. M E T H O D S In January of 2011, a library faculty ...
After Testing, Novel Bladder Cancer Treatments Win Approval
NYU Langone trials have led to approval for a new batch of drug therapies effective in treating bladder cancer in older patients.
Mammogram Screening for Women with the BRCA Gene Mutation
NYU Langone expert Dr. Julia A. Smith discusses screening options for women with the BRCA gene mutation or other risk factors for breast cancer.
New Treatment Helps Fight Triple-Negative Breast Cancer
New study from NYU Langone expert Dr. Sylvia Adams shows promising treatment for people who have triple-negative breast cancer.
NYU Langone Health in the News—April 16, 2024
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from April 16, 2024.
Study Finds Two Opioid Treatments Equally Effective
Two opioid treatments are equally effective, finds a study published by Dr. John Rotrosen and Dr. Joshua Lee of NYU Langone in the Lancet.